210 related articles for article (PubMed ID: 19063738)
21. [Prevalence survey of cardiovascular risk factors in the general population in St. Louis (Senegal)].
Pessinaba S; Mbaye A; Yabéta GA; Harouna H; Sib AE; Kane AD; Bodian M; Ndiaye MB; Mbaye-Ndour M; Niang K; Diagne-Sow D; Diack B; Kane M; Diao M; Mathieu JB; Kane A
Ann Cardiol Angeiol (Paris); 2013 Aug; 62(4):253-8. PubMed ID: 23540763
[TBL] [Abstract][Full Text] [Related]
22. Fifteen-year trends in cardiovascular risk factors (1980-1982 through 1995-1997): the Minnesota Heart Survey.
Arnett DK; McGovern PG; Jacobs DR; Shahar E; Duval S; Blackburn H; Luepker RV
Am J Epidemiol; 2002 Nov; 156(10):929-35. PubMed ID: 12419765
[TBL] [Abstract][Full Text] [Related]
23. Relations between Helicobacter pylori, thyroid disease and cardiovascular risk factors in a 56-65-year-old population.
Nilsson T; Lapidus L; Lindstedt G; Nyström E; Eggertsen R
Scand J Prim Health Care; 2000 Jun; 18(2):111-2. PubMed ID: 10944066
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of cardiovascular risk factors in Greece: aims, design and baseline characteristics of the ATTICA study.
Pitsavos C; Panagiotakos DB; Chrysohoou C; Stefanadis C
BMC Public Health; 2003 Oct; 3():32. PubMed ID: 14567760
[TBL] [Abstract][Full Text] [Related]
25. Leisure time physical activity in middle age predicts the metabolic syndrome in old age: results of a 28-year follow-up of men in the Oslo study.
Holme I; Tonstad S; Sogaard AJ; Larsen PG; Haheim LL
BMC Public Health; 2007 Jul; 7():154. PubMed ID: 17625024
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of cardiometabolic risk factors among professional male long-distance bus drivers in Lagos, south-west Nigeria: a cross-sectional study.
Amadi CE; Grove TP; Mbakwem AC; Ozoh OB; Kushimo OA; Wood DA; Akinkunmi M
Cardiovasc J Afr; 2018 Mar/Apr 23; 29(2):106-114. PubMed ID: 29457826
[TBL] [Abstract][Full Text] [Related]
27. High prevalence of metabolic risk factors for cardiovascular diseases among Saudi population, aged 30-64 years.
Rahman Al-Nuaim A
Int J Cardiol; 1997 Dec; 62(3):227-35. PubMed ID: 9476683
[TBL] [Abstract][Full Text] [Related]
28. Impact of 4 different definitions used for the assessment of the prevalence of the Metabolic Syndrome in primary healthcare: The German Metabolic and Cardiovascular Risk Project (GEMCAS).
Moebus S; Hanisch JU; Aidelsburger P; Bramlage P; Wasem J; Jöckel KH
Cardiovasc Diabetol; 2007 Sep; 6():22. PubMed ID: 17822558
[TBL] [Abstract][Full Text] [Related]
29. Secular trends in cardiovascular risk factors with a 36-year perspective: observations from 38- and 50-year-olds in the Population Study of Women in Gothenburg.
Björkelund C; Andersson-Hange D; Andersson K; Bengtsson C; Blomstrand A; Bondyr-Carlsson D; Eiben G; Rödström K; Sjöberg A; Sundh V; Weman L; Zylberstein D; Hakeberg M; Lissner L
Scand J Prim Health Care; 2008; 26(3):140-6. PubMed ID: 18609256
[TBL] [Abstract][Full Text] [Related]
30. Trends in cardiovascular risk factors among people with diabetes in a population based study, Health Survey for England 1994-2009.
Samaranayaka S; Gulliford MC
Prim Care Diabetes; 2013 Oct; 7(3):193-8. PubMed ID: 23685024
[TBL] [Abstract][Full Text] [Related]
31. A prevalence of cardiometabolic risk factors among a rural Yoruba south-western Nigerian population: a population-based survey.
Oladapo OO; Salako L; Sodiq O; Shoyinka K; Adedapo K; Falase AO
Cardiovasc J Afr; 2010; 21(1):26-31. PubMed ID: 20224842
[TBL] [Abstract][Full Text] [Related]
32. Follicle-Stimulating Hormone, Its Association with Cardiometabolic Risk Factors, and 10-Year Risk of Cardiovascular Disease in Postmenopausal Women.
Wang N; Shao H; Chen Y; Xia F; Chi C; Li Q; Han B; Teng Y; Lu Y
J Am Heart Assoc; 2017 Aug; 6(9):. PubMed ID: 28855169
[TBL] [Abstract][Full Text] [Related]
33. Sex-specific clustering of metabolic risk factors and their association with incident cardiovascular diseases: A population-based prospective study.
Ramezankhani A; Azizi F; Hadaegh F; Eskandari F
Atherosclerosis; 2017 Aug; 263():249-256. PubMed ID: 28683364
[TBL] [Abstract][Full Text] [Related]
34. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study.
Eckel N; Li Y; Kuxhaus O; Stefan N; Hu FB; Schulze MB
Lancet Diabetes Endocrinol; 2018 Sep; 6(9):714-724. PubMed ID: 29859908
[TBL] [Abstract][Full Text] [Related]
35. CA.ME.LI.A. An epidemiological study on the prevalence of CArdiovascular, MEtabolic, LIver and Autoimmune diseases in Northern Italy.
Bignotto M; Dei Cas M; Paroni R; Bianco E; Zermiani P; Gangale MG; Zadro V; Maregatti M; Piagnani A; Russo A; Baldassarre D; Folli F; Battezzati PM; Zuin M
Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1416-1426. PubMed ID: 33814235
[TBL] [Abstract][Full Text] [Related]
36. Prevalence, pharmacological treatment, and control of cardiometabolic risk factors among older people in central Stockholm: a population-based study.
Wang R; Fratiglioni L; Liang Y; Welmer AK; Xu W; Mangialasche F; Johnell K; Qiu C
PLoS One; 2015; 10(3):e0119582. PubMed ID: 25799502
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of metabolic syndrome-related disorders in a large adult population in Turkey.
Sanisoglu SY; Oktenli C; Hasimi A; Yokusoglu M; Ugurlu M
BMC Public Health; 2006 Apr; 6():92. PubMed ID: 16606462
[TBL] [Abstract][Full Text] [Related]
38. Anthropometric measurements in childhood and prediction of cardiovascular risk factors in adulthood: Kaunas cardiovascular risk cohort study.
Petkeviciene J; Klumbiene J; Kriaucioniene V; Raskiliene A; Sakyte E; Ceponiene I
BMC Public Health; 2015 Mar; 15():218. PubMed ID: 25880559
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of modifiable cardiovascular risk factors in German adolescents.
Müller-Riemenschneider F; Nocon M; Willich SN
Eur J Cardiovasc Prev Rehabil; 2010 Apr; 17(2):204-10. PubMed ID: 19996972
[TBL] [Abstract][Full Text] [Related]
40. Application of recent definitions of the metabolic syndrome to survey data from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE II).
Deedwania PC; Maki KC; Dicklin MR; Stone NJ; Ballantyne CM; Davidson MH
J Cardiometab Syndr; 2006; 1(5):295-300. PubMed ID: 17679790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
